{
    "clinical_study": {
        "@rank": "77399", 
        "arm_group": {
            "arm_group_label": "Endovascular AVF (EndoAVF)", 
            "arm_group_type": "Experimental", 
            "description": "The FLEX System will be used to endovascularly create a fistula in CKD patients who require hemodialysis vascular access."
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this clinical study is to evaluate the preliminary safety and\n      effectiveness of using the FLEX-1 device for the creation of an arteriovenous fistula (AVF)\n      in patients requiring chronic hemodialysis."
        }, 
        "brief_title": "A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Kidney Disease (CKD)", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eligible for a native surgical arteriovenous fistula, as determined by the treating\n             physician.\n\n          -  Adult (age >18 years old).\n\n          -  Advanced chronic kidney disease (CKD), stage 4 or 5 electing for hemodialysis.\n\n          -  Written informed consent obtained"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02119845", 
            "org_study_id": "FLEX-1-001"
        }, 
        "intervention": {
            "arm_group_label": "Endovascular AVF (EndoAVF)", 
            "description": "The FLEX System will be used to endovascularly create a fistula in CKD patients who require hemodialysis vascular access.", 
            "intervention_name": "Endovascular AVF (EndoAVF)", 
            "intervention_type": "Device", 
            "other_name": "FLEX"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic kidney disease", 
            "Arteriovenous fistula (AVF)", 
            "Hemodialysis", 
            "Vascular access", 
            "Endovascular AVF (EndoAVF)"
        ], 
        "lastchanged_date": "April 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Asuncion", 
                    "country": "Paraguay", 
                    "zip": "1001-1925"
                }, 
                "name": "Italian Hospital"
            }
        }, 
        "location_countries": {
            "country": "Paraguay"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective Clinical Evaluation of the TVA FLEX-1 Device Protocol FLEX-1-001", 
        "overall_official": {
            "affiliation": "Italian Hospital", 
            "last_name": "Adrian Ebner, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Paraguay:  Ministry of Public Health and Social Wellbeing", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The safety of the FLEX-1 system based on the overall complication rates derived from adverse event data.", 
            "measure": "Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02119845"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The functionality of the AVF will be measured based on use of the AVF with two needles for at least 75% of dialysis sessions over a 4-week period following at least a one month maturation period.", 
            "measure": "Access Functionality", 
            "safety_issue": "No", 
            "time_frame": "6 Months"
        }, 
        "source": "TVA Medical Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "TVA Medical Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}